Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab in Severe Uncontrolled Asthma (ANDHI)
NCT03170271Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2017
- Primary completion
- Sep 2019
- Modality
- Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Jul 2017; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03170271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03170271.